EIF2S1 Antikörper
EIF2S1
Reaktivität: Human
WB, IHC
Wirt: Kaninchen
Polyclonal
unconjugated
Produktnummer ABIN2258455
-
-
Target
Alle EIF2S1 Antikörper anzeigen
-
EIF2S1
(Eukaryotic Translation Initiation Factor 2 Subunit 1 (EIF2S1))
-
Reaktivität
-
Human
-
Wirt
-
Kaninchen
-
Klonalität
-
Polyklonal
-
Konjugat
-
Dieser EIF2S1 Antikörper ist unkonjugiert
-
Applikation
-
Western Blotting (WB), Immunohistochemistry (IHC)
-
Kreuzreaktivität
-
Human
-
Kreuzreaktivität (Details)
-
Calculated cross reactivity: Hu
-
Produktmerkmale
-
EIF2S1 (EIF2, EIF2A, eIF-2alpha, Eukaryotic translation initiation factor 2 subunit alpha, eukaryotic translation initiation factor 2, subunit 1 (alpha, 35kD ))
-
Aufreinigung
-
Purified by immunoaffinity chromatography.
-
Immunogen
-
A synthetic peptide corresponding to a sequence in the middle region of human EIF2S1.
-
Isotyp
-
IgG
-
Top Product
-
Discover our top product EIF2S1 Primärantikörper
-
-
-
Applikationshinweise
-
Optimal working conditions should be determined by the investigator.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Format
-
Lyophilized
-
Rekonstitution
-
Reconstitution: Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Buffer
-
Supplied as a lyophilized powder. Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.
-
Konservierungsmittel
-
Sodium azide, Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
-
This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Lagerung
-
4 °C,-20 °C
-
Informationen zur Lagerung
-
4°C/-20°C
-
-
Target
-
EIF2S1
(Eukaryotic Translation Initiation Factor 2 Subunit 1 (EIF2S1))
-
Andere Bezeichnung
-
EIF2S1 (EIF2S1 Produkte)
-
Synonyme
-
EIF-2 antikoerper, EIF-2A antikoerper, EIF-2alpha antikoerper, EIF2 antikoerper, EIF2A antikoerper, Eif2s1 antikoerper, eif2s1l antikoerper, fb36a08 antikoerper, wu:fb36a08 antikoerper, zgc:56510 antikoerper, 0910001O23Rik antikoerper, 2410026C18Rik antikoerper, 35kDa antikoerper, Eif2a antikoerper, eIF2alpha antikoerper, eif2a antikoerper, CG9946 antikoerper, Dmel\\CG9946 antikoerper, Eif2alpha antikoerper, IF2A_DROME antikoerper, M(1)14C antikoerper, M(1)19-153 antikoerper, M(1)8e3-10 antikoerper, deIF2alpha antikoerper, eIF-2 antikoerper, eIF-2 a antikoerper, eIF-2 alpha antikoerper, eIF2 alpha antikoerper, eIF2-alpha antikoerper, eIF2a antikoerper, eiF-2alpha antikoerper, elF2alpha antikoerper, l(1)14Cf antikoerper, l(1)19-153 antikoerper, eukaryotic translation initiation factor 2 subunit alpha antikoerper, eukaryotic translation initiation factor 2, subunit 1 alpha a antikoerper, eukaryotic translation initiation factor 2, subunit 1 alpha antikoerper, eukaryotic translation initiation factor 2 alpha subunit antikoerper, Eukaryotic translation initiation factor 2 subunit 1 antikoerper, eukaryotic translation initiation factor 2 subunit alpha L homeolog antikoerper, eukaryotic translation Initiation Factor 2alpha antikoerper, EIF2S1 antikoerper, eif2s1a antikoerper, Eif2s1 antikoerper, eif2s1 antikoerper, LOC693063 antikoerper, CNI00230 antikoerper, THAPSDRAFT_105 antikoerper, if2a antikoerper, eif2s1.L antikoerper, eIF-2alpha antikoerper
-
UniProt
-
P05198
-
Pathways
-
Ribonucleoprotein Complex Subunit Organization, ER-Nucleus Signaling, Hepatitis C
-